CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

All Indications

Primary IgAN (IgA Nephropathy) to slow decline of kidney function in adults at risk of disease progression

1

Companies

1

Drug Programs

0

Phase 3

0

Upcoming PDUFAs

Competitors
Development Stage Distribution
Approved
1
PDUFA Timeline
No upcoming PDUFA dates for this indication.

Not financial advice

Signals are probabilistic and based on historical data — past performance doesn't guarantee future results. Do your own research.